Vineet Laboratories (NSE:VINEETLAB) LT-Debt-to-Total-Asset: 0.00 (As of Dec. 2025)

What is Vineet Laboratories LT-Debt-to-Total-Asset?

Vineet Laboratories NSE:VINEETLAB +0.09% 41 LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus rates NSE:VINEETLAB with a GF Score™ of 41/100 and a GF Value™ of ₹15.35 (Significantly Overvalued). The stock has 6 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Vineet Laboratories's long-term debt to total assests ratio for the quarter that ended in Dec. 2025 was 0.00.

Vineet Laboratories's long-term debt to total assets ratio declined from Dec. 2024 (0.05) to Dec. 2025 (0.00). It may suggest that Vineet Laboratories is progressively becoming less dependent on debt to grow their business.

Vineet Laboratories (NSE:VINEETLAB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Vineet Laboratories LT-Debt-to-Total-Asset Related Terms

Vineet Laboratories LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Vineet Laboratories's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vineet Laboratories LT-Debt-to-Total-Asset Chart

Vineet Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.03

0.01

0.04

0.03

0.04

Vineet Laboratories Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.05	0.04	0.05	0.07	0.00

41GF Score

Vineet Laboratories Ltd NSE:VINEETLAB

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vineet Laboratories LT-Debt-to-Total-Asset Calculation

Vineet Laboratories's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as

LT Debt to Total Assets (A: Mar. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2025 )	/	Total Assets (A: Mar. 2025 )
	=	37.859	/	945.401
	=	0.04

Vineet Laboratories's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (Q: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2025 )	/	Total Assets (Q: Dec. 2025 )
	=	0	/	0
	=

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.00 mean?

Vineet Laboratories (NSE:VINEETLAB) has a LT-Debt-to-Total-Asset of 0.00 as of Dec. 2025. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Vineet Laboratories and its competitors.

Is Vineet Laboratories' LT-Debt-to-Total-Asset too high?

Vineet Laboratories' current LT-Debt-to-Total-Asset is 0.00. Overall, Vineet Laboratories has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Vineet Laboratories' LT-Debt-to-Total-Asset compare to DOW?

Vineet Laboratories' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Chemicals company?

A good LT-Debt-to-Total-Asset depends on the Chemicals industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Vineet Laboratories and its competitors. Vineet Laboratories's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vineet Laboratories stock overvalued right now?

Based on GuruFocus' analysis, Vineet Laboratories (NSE:VINEETLAB) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹15.35, compared to a current price of ₹33.65 — trading 119.2% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Vineet Laboratories' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Vineet Laboratories (NSE:VINEETLAB), the current LT-Debt-to-Total-Asset is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vineet Laboratories (NSE:VINEETLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Vineet Laboratories stock appears to be overvalued. The current stock price of ₹33.65 is trading 119.2% above its estimated GF Value™ of ₹15.35. GuruFocus considers Vineet Laboratories to be Significantly Overvalued.

Key valuation signals for NSE:VINEETLAB:

LT-Debt-to-Total-Asset: 0.00
GF Value™: ₹15.35 vs. price of ₹33.65 (119.2% above fair value)
GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the NSE:VINEETLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vineet Laboratories Business Description

Industry Basic Materials Chemicals

Comparable Companies BOM:506734 BOM:530125 BOM:524564 BOM:538634 BOM:544778 BOM:519097 BOM:530757 BOM:506640 BOM:530991 BOM:500358 TSE:4063 XTER:BAS SAU:2010 SZSE:002080 SHSE:600989 DOW SHSE:600160 TSE:4004 SHSE:600346 SZSE:002460

Other Exchanges 543298:India

Address 5-5-160, Malleswari Nilayam, Chintalakunta, Opposite Vishnu Theatre, L.B Nagar, Hyderabad, TG, IND, 500074

Website https://www.vineetlabs.co.in

Vineet Laboratories Ltd is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Nitrophenyl phosphate disodium salt, and others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, the manufacture of Drug Intermediates & Bulk Dugs.

41GF Score

Get the complete analysis for NSE:VINEETLAB

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹33.65

Price

₹15.35

GF Value

View NSE:VINEETLAB Analysis

See LT-Debt-to-Total-Asset data for all stocks →